Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112682163 | 11268216 | 3 | F | 2013 | 20160510 | 20150714 | 20160817 | PER | US-ASTRAZENECA-2015SE64278 | ASTRAZENECA | 761.00 | MON | M | Y | 77.10000 | KG | 20160817 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112682163 | 11268216 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, ONE PUFF TWO TIMES A DAY | 3000984C00 | 21929 | |||||||||
| 112682163 | 11268216 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, TWO PUFFS TWO TIMES A DAY | 3000984C00 | 21929 | |||||||||
| 112682163 | 11268216 | 3 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, 3-4 TIMES PER DAY AS REQUIRED | 3000984C00 | 21929 | |||||||||
| 112682163 | 11268216 | 4 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, 3-4 TIMES PER DAY AS REQUIRED | 21929 | ||||||||||
| 112682163 | 11268216 | 5 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 112682163 | 11268216 | 6 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 112682163 | 11268216 | 7 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 0 | 80 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112682163 | 11268216 | 1 | Chronic obstructive pulmonary disease |
| 112682163 | 11268216 | 2 | Chronic obstructive pulmonary disease |
| 112682163 | 11268216 | 3 | Chronic obstructive pulmonary disease |
| 112682163 | 11268216 | 4 | Chronic obstructive pulmonary disease |
| 112682163 | 11268216 | 5 | Blood pressure abnormal |
| 112682163 | 11268216 | 6 | Stent placement |
| 112682163 | 11268216 | 7 | Blood cholesterol abnormal |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112682163 | 11268216 | Chronic obstructive pulmonary disease | |
| 112682163 | 11268216 | Cough | |
| 112682163 | 11268216 | Drug ineffective | |
| 112682163 | 11268216 | Intentional product misuse | |
| 112682163 | 11268216 | Malaise | |
| 112682163 | 11268216 | Off label use | |
| 112682163 | 11268216 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112682163 | 11268216 | 1 | 2013 | 0 | ||
| 112682163 | 11268216 | 2 | 2013 | 0 | ||
| 112682163 | 11268216 | 3 | 2013 | 0 | ||
| 112682163 | 11268216 | 4 | 201506 | 0 | ||
| 112682163 | 11268216 | 5 | 2010 | 0 | ||
| 112682163 | 11268216 | 6 | 2010 | 0 | ||
| 112682163 | 11268216 | 7 | 2010 | 0 |